MCL coexpression mm9:597
From FANTOM5_SSTAR
Phase1 CAGE Peaks
Short description | |
---|---|
Mm9::chr11:113612097..113612161,- | p3@Cdc42ep4 |
Mm9::chr11:120434178..120434195,- | p1@P4hb |
Mm9::chr13:115879674..115879694,+ | p@chr13:115879674..115879694 + |
Mm9::chr13:115879700..115879724,+ | p@chr13:115879700..115879724 + |
Mm9::chr18:57514387..57514451,+ | p1@Prrc1 |
Mm9::chr3:122970363..122970418,+ | p1@Sec24d |
Mm9::chr3:40886914..40886946,- | p1@Pgrmc2 |
Mm9::chr4:118217520..118217535,- | p@chr4:118217520..118217535 - |
Mm9::chr5:100845134..100845301,- | p1@Sec31a |
Mm9::chr5:115420882..115420896,- | p3@Hnf1a |
Mm9::chr5:144165498..144165561,+ | p1@Kdelr2 |
Mm9::chr5:23934029..23934061,+ | p3@Slc4a2 |
Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data
GO ID | GO name | FDR corrected p-value |
---|---|---|
GO:0008104 | protein localization | 0.0320997394001498 |
GO:0033036 | macromolecule localization | 0.0320997394001498 |
GO:0046483 | heterocycle metabolic process | 0.0320997394001498 |
GO:0043691 | reverse cholesterol transport | 0.0320997394001498 |
GO:0005046 | KDEL sequence binding | 0.0320997394001498 |
GO:0015721 | bile acid and bile salt transport | 0.0320997394001498 |
GO:0004656 | procollagen-proline 4-dioxygenase activity | 0.0320997394001498 |
GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline | 0.0320997394001498 |
GO:0019511 | peptidyl-proline hydroxylation | 0.0320997394001498 |
GO:0031545 | peptidyl-proline 4-dioxygenase activity | 0.0320997394001498 |
GO:0046923 | ER retention sequence binding | 0.0320997394001498 |
GO:0006621 | protein retention in ER | 0.0320997394001498 |
GO:0019471 | 4-hydroxyproline metabolic process | 0.0320997394001498 |
GO:0009743 | response to carbohydrate stimulus | 0.0320997394001498 |
GO:0006699 | bile acid biosynthetic process | 0.0320997394001498 |
GO:0009746 | response to hexose stimulus | 0.0320997394001498 |
GO:0009749 | response to glucose stimulus | 0.0320997394001498 |
GO:0018208 | peptidyl-proline modification | 0.0320997394001498 |
GO:0006810 | transport | 0.0320997394001498 |
GO:0015908 | fatty acid transport | 0.0320997394001498 |
GO:0051234 | establishment of localization | 0.0320997394001498 |
GO:0015031 | protein transport | 0.0320997394001498 |
GO:0048341 | paraxial mesoderm formation | 0.0320997394001498 |
GO:0031543 | peptidyl-proline dioxygenase activity | 0.0320997394001498 |
GO:0019798 | procollagen-proline dioxygenase activity | 0.0320997394001498 |
GO:0015718 | monocarboxylic acid transport | 0.0320997394001498 |
GO:0032507 | maintenance of cellular protein localization | 0.0320997394001498 |
GO:0042802 | identical protein binding | 0.0320997394001498 |
GO:0045184 | establishment of protein localization | 0.0320997394001498 |
GO:0016864 | intramolecular oxidoreductase activity, transposing S-S bonds | 0.0320997394001498 |
GO:0003756 | protein disulfide isomerase activity | 0.0320997394001498 |
GO:0031018 | endocrine pancreas development | 0.0320997394001498 |
GO:0005783 | endoplasmic reticulum | 0.0326021141895586 |
GO:0051651 | maintenance of cellular localization | 0.0326021141895586 |
GO:0016862 | intramolecular oxidoreductase activity, interconverting keto- and enol-groups | 0.0326021141895586 |
GO:0005452 | inorganic anion exchanger activity | 0.0326021141895586 |
GO:0005048 | signal sequence binding | 0.0338486238688349 |
GO:0048340 | paraxial mesoderm morphogenesis | 0.0338486238688349 |
GO:0045185 | maintenance of protein localization | 0.0338486238688349 |
GO:0051179 | localization | 0.0343283832004196 |
GO:0015380 | anion exchanger activity | 0.0350596560803832 |
GO:0008206 | bile acid metabolic process | 0.0350596560803832 |
GO:0015106 | bicarbonate transmembrane transporter activity | 0.0350596560803832 |
GO:0050796 | regulation of insulin secretion | 0.0350596560803832 |
GO:0015301 | anion:anion antiporter activity | 0.0350596560803832 |
GO:0006783 | heme biosynthetic process | 0.0350596560803832 |
GO:0015108 | chloride transmembrane transporter activity | 0.0373555961627596 |
GO:0006779 | porphyrin biosynthetic process | 0.0373555961627596 |
GO:0048339 | paraxial mesoderm development | 0.0373555961627596 |
GO:0033014 | tetrapyrrole biosynthetic process | 0.0373555961627596 |
GO:0031016 | pancreas development | 0.0373555961627596 |
GO:0045120 | pronucleus | 0.0385486000284395 |
GO:0030301 | cholesterol transport | 0.0385486000284395 |
GO:0015918 | sterol transport | 0.0385486000284395 |
GO:0051235 | maintenance of localization | 0.0385486000284395 |
GO:0045453 | bone resorption | 0.0385486000284395 |
GO:0001750 | photoreceptor outer segment | 0.0385486000284395 |
GO:0042168 | heme metabolic process | 0.0404007155440419 |
GO:0031513 | nonmotile primary cilium | 0.0421889621772222 |
GO:0033013 | tetrapyrrole metabolic process | 0.0431965906050089 |
GO:0006778 | porphyrin metabolic process | 0.0431965906050089 |
GO:0046883 | regulation of hormone secretion | 0.0472013970439534 |
GO:0001889 | liver development | 0.0484875740425892 |
GO:0042592 | homeostatic process | 0.0484875740425892 |
GO:0030111 | regulation of Wnt receptor signaling pathway | 0.049503468730572 |
Relative expression of the co-expression cluster over median <br>Analyst:
Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>
Ontology term | p-value | n |
---|
Ontology term | p-value | n |
---|
Ontology term | p-value | n |
---|
TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data
Novel motifs
JASPAR motifs
Motifs | -log10(p-value) |
---|---|
{{{tfbs_overrepresentation_jaspar}}} |